Effect of Neuromuscular Electrical Stimulation on Muscle Mass in ECMO Patients (NMES-ECMO)
Effectiveness of Neuromuscular Electrical Stimulation in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation
The goal of this clinical trial study: is to determine the effectiveness of neuromuscular electrical stimulation in critically ill patients undergoing extracorporeal membrane oxygenation.
The main questions it aims to answer are:
- Does NMES has an effect when added to conventional protocol for ECMO patients?
- Does NMES will help in preserve muscle mass?
- Patients will recieve the treatment untill discharge.
- Assesment will be done before and after treatement
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Subjects:
Fifty Patients from both genders with pulmonary or cardiac disease receiving extracorporeal membrane oxygenation will participate in this study. They will randomly have divided into two groups equal in numb.Their ages will be ranged from 20 to 50 years.
- Design of the study:
In this study the patients will be randomly assigned into two equal groups (25 patients for each group):
Group A (Study group):
This group includes 25 patients who will receive VMS current of NMES on quadriceps muscle bilateral for 30 min daily for one week in addition to conventional physiotherapy program (Range of motion exercises, Positioning,Strengthening exercises and Stretching exercises).
- Group B (Control group):
This group will include 25 patients. The participants will receive conventional physiotherapy program (Range of motion exercises, Positioning,Strengthening exercises and Stretching exercises) two times per day for one week.
- Equipments:
Measurement equipments:
A-Evaluating muscle strength The Medical Research Council (MRC) Scale for Muscle Strength B-Evaluating muscle mass Ultrasonography for assessing quadriceps muscle mass applied by ACUSON P500 manufactured by SEIMENS made in USA C-Evaluating level of activity ICU Mobility scale (IMS): IMS provides a sensitive 11-point ordinal scale, ranging from nothing (lying/passive exercises in bed, score of 0) to independent ambulation (score of 10).
D- Hospital length of stay (LOS) days E-Discharge destination Discharge destination was ranked on an ordinal scale: 0 = mortality; 1 = discharge to inpatient hospice; 2 = discharge to long-term acute care facility equivalent to ventilator weaning and skilled nursing facilities; 3 = discharge to acute and subacute care rehabilitation facilities; 4 = discharge to home with home health rehabilitation services; and 5 = discharge to home with no services.
F- Incidence and type of ECMO complication
- Treatmenet Procedures: NMES will be applied by using DJO/ Chattanooga - USA 2023 Patients on ECMO will receive daily 30-minute of neuromuscular electrical stimulation VMS current / on the quadriceps femoris muscles (rectus femoris and vastus intermedius) bilaterally as long as they were on ECMO to preserve muscle mass. Patients will be supine lying with knee slight flexion 40 degree by billow. 2 rectangular carbon electrodes (6×8 cm) on the muscle motor point, Frequency 50 pps , with a 1000 usec phase duration, ramp 5 sec, duty cycle 1:5.
The conventional program for both groups:
(Early mobilization started passively and progressed to be active, and progressed from in bed mobility to out of bed mobility, Mobilization activities, Passive- and active-assisted movements of extremities, Sitting on a chair, Bedside standing, Walking with support).
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Ehssan R Mahmoud, Master
- Número de teléfono: +20 1096403137
- Correo electrónico: ehssan.rabie.98@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Rana H Elbanna, Assist.Prof
- Número de teléfono: +20 1062070686
Ubicaciones de estudio
-
-
Giza, Dokki
-
Cairo, Giza, Dokki, Egipto, 11432
- Faculty of Physical Therapy
-
Contacto:
- Rana H Elbanna, Assist.Prof
- Número de teléfono: +20 1062070686
-
Contacto:
- Nesreen G Alnahas, Professor
- Número de teléfono: +20 1002227242
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Adult patients of both sexes aged 20 to 50 years
- Patients receiving extracorporeal membrane oxygenation (ECMO) (veno-venous or veno- arterial)
- Patients admitted to the ECMO unit for at least 72 hours
- Hemodynamically stable patients as determined by the treating medical team
- Patients medically eligible for participation in physiotherapy and neuromuscular electrical stimulation (NMES)
Exclusion Criteria:
- Hemodynamic instability
- Patients requiring ECMO support for less than 72 hours
- Unstable cardiac arrhythmias
- Hemorrhagic shock
- Deep venous thrombosis or pulmonary embolism
- Lower limb open wounds or acute skin burns at electrode placement sites
- Pregnant patients
- Patients receiving intra-aortic balloon pump (IABP) support
- Any contraindication to NMES application
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: NMES group
Intervention Name: Neuromuscular Electrical Stimulation (NMES) + Conventional Physiotherapy Intervention Type: Other Intervention Description: Patients will receive neuromuscular electrical stimulation (NMES) in addition to a conventional physiotherapy program while undergoing ECMO. NMES will be applied bilaterally to the quadriceps femoris muscles using a VMS current for 30 minutes daily for one week. Stimulation parameters will include a frequency of 50 pulses per second, pulse duration of 1000 microseconds, ramp time of 5 seconds, and a duty cycle of 1:5. Two rectangular carbon electrodes (6 × 8 cm) will be placed over the motor points of the targeted muscles. Patients will be positioned in a supine position with slight knee flexion (approximately 40 degrees). In addition, they will receive a conventional physiotherapy program twice daily(passive and active-assisted range of motion exercises, bed mobility, sitting, standing, and ambulation). |
NMES will be applied bilaterally to the quadriceps femoris muscles (rectus femoris and vastus intermedius) for 30 minutes daily for one week. Stimulation parameters will include a frequency of 50 pulses per second, pulse duration of 1000 microseconds, ramp time of 5 seconds, and a duty cycle of 1:5. Two rectangular carbon electrodes (6 × 8 cm) will be placed over the motor points of the targeted muscles. Patients will be positioned in supine lying with approximately 40 degrees knee flexion. In addition, participants will receive a conventional physiotherapy program twice daily, including passive and active-assisted range of motion exercises, early mobilization, bed mobility, sitting, standing, and ambulation. |
|
Comparador activo: Conventional PT
Intervention Name: Conventional Physiotherapy Program Intervention Type: Other Intervention Description: Participants will receive a conventional physiotherapy program only, administered twice daily for one week during ECMO support. The program will include early mobilization starting with passive movements and progressing to active-assisted and active exercises as tolerated. Rehabilitation activities will include in-bed mobility, sitting at the edge of the bed, standing, and assisted ambulation based on patient condition and tolerance. No neuromuscular electrical stimulation will be applied in this group. |
Participants in this group will receive a conventional physiotherapy program only during extracorporeal membrane oxygenation (ECMO) support. The program will be administered twice daily for one week. The intervention will include early mobilization strategies starting with passive range of motion exercises and progressing to active-assisted and active exercises as tolerated. Rehabilitation activities will include bed mobility, sitting at the edge of the bed, bedside standing, and assisted ambulation according to patient tolerance and clinical stability. All interventions will be delivered according to standard ICU physiotherapy practices. Neuromuscular electrical stimulation (NMES) will not be applied in this group.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in quadriceps muscle mass
Periodo de tiempo: Baseline and after 7 days of intervention
|
Quadriceps muscle mass will be assessed using ultrasonography by measuring muscle thickness and/or cross-sectional area of the rectus femoris muscle.
Measurements will be performed at baseline (before intervention) and after one week of intervention during ECMO support.
The primary endpoint will be the change in muscle mass over time between groups.
|
Baseline and after 7 days of intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Muscle strength (Medical Research Council Scale - MRC)
Periodo de tiempo: Baseline and after 7 days of intervention
|
Muscle strength will be assessed using the Medical Research Council (MRC) scale for major muscle groups.
The total MRC score will be recorded to evaluate global muscle strength.
|
Baseline and after 7 days of intervention
|
|
Level of mobility (ICU Mobility Scale - IMS)
Periodo de tiempo: Baseline and after 7 days of intervention
|
Functional mobility will be assessed using the ICU Mobility Scale (IMS), an 11-point ordinal scale ranging from 0 (lying in bed) to 10 (independent ambulation).
|
Baseline and after 7 days of intervention
|
|
Hospital Length of Stay (LOS)
Periodo de tiempo: From day 1 up to 90 days
|
Length of hospital stay will be measured as the total number of days from ICU admission to hospital discharge.
|
From day 1 up to 90 days
|
|
Discharge destination
Periodo de tiempo: From day 1 up to 90 days
|
Discharge destination will be assessed using an ordinal scale: 0 = mortality;
|
From day 1 up to 90 days
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Rana H Elbanna, Assist.Prof, Faculty of Physical Therapy
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- P.T.REC/012/006074
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .